GlassScriptPhysician profile
Zachary Morrow
NPI 1861028797
$1,810.70
in general payments reported to CMS, 2019-2025
10 companies · $1,796 in 2025
The $1,796 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $14.96 · 2025: $1,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189 · Travel and Lodging: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.73 |
| Travel and Lodging | $621.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $650.68 | 2025 | Clottriever Bold Catheter, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $426.45 | 2025 | |
| Abiomed | $282.84 | 2025 | |
| Amgen INC. | $154.96 | 2024-2025 | Repatha, Repatha |
| Medtronic, INC. | $91.80 | 2025 | Aurora Ev-Icd Mri Surescan, Spiderfx |
| Abbott Laboratories | $57.84 | 2025 | Optis, Dragonfly Opstar, Ultreon |
| Atricure, INC. | $55.85 | 2025 | Atriclip Laa Exclusion System |
| Novartis Pharmaceuticals Corporation | $37.89 | 2025 | |
| Alnylam Pharmaceuticals INC. | $35.28 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $17.11 | 2025 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Morrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.